Viewing Study NCT03433469


Ignite Creation Date: 2025-12-24 @ 10:55 PM
Ignite Modification Date: 2025-12-25 @ 8:23 PM
Study NCT ID: NCT03433469
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-01-31
First Post: 2018-01-25
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Osimertinib in Treating Participants With Stage I-IIIA EGFR-mutant Non-small Cell Lung Cancer Before Surgery
Sponsor: University of California, San Francisco
Organization: